116 related articles for article (PubMed ID: 477192)
1. Hypertension with mineralocorticoid administration to the Long-Evans rat.
Holland OB; Gomez-Sanchez C; Ziegler T
Clin Sci (Lond); 1979 Feb; 56(2):109-13. PubMed ID: 477192
[TBL] [Abstract][Full Text] [Related]
2. 5 alpha-Dihydro-11-deoxycorticosterone: effect on blood pressure in the rat.
Carroll J; Komanicky P; Melby JC
Steroids; 1981 Jan; 37(1):111-20. PubMed ID: 7222141
[TBL] [Abstract][Full Text] [Related]
3. Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D
Endocrinology; 1979 Sep; 105(3):600-4. PubMed ID: 157270
[TBL] [Abstract][Full Text] [Related]
4. Effects of mineralocorticoids and glucocorticoids on compensatory adrenal growth in rats.
Phillips R; Crock C; Funder J
Am J Physiol; 1985 Apr; 248(4 Pt 1):E450-6. PubMed ID: 3985143
[TBL] [Abstract][Full Text] [Related]
5. Effect of 6-dehydro-DOCA and 6-dehydro-9 alpha-fluorocortisol acetate on the excretion of sodium and potassium in the rat.
Genard P; Palem-Vliers M
J Steroid Biochem; 1985 Nov; 23(5A):673-5. PubMed ID: 4079383
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid and hypertensive effects of 19-nor-progesterone.
Hall CE; Gomez-Sanchez CE; Hungerford S; Gomez-Sanchez EP
Endocrinology; 1981 Oct; 109(4):1168-75. PubMed ID: 7285865
[TBL] [Abstract][Full Text] [Related]
8. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O
Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064
[TBL] [Abstract][Full Text] [Related]
9. The occurrence of 11-deoxycorticosterone (DOC)-induced hypertension in the Long-Evans rat.
Brownie AC; Gallant S; Nickerson PA; Joseph LM
Endocr Res Commun; 1978; 5(1):71-80. PubMed ID: 710367
[TBL] [Abstract][Full Text] [Related]
10. Resistance to mineralocorticoids in Wistar-Furth rats.
Ullian ME; Islam MM; Robinson CJ; Fitzgibbon WR; Tobin ET; Paul RV
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1454-61. PubMed ID: 9087624
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension.
Banes AK; Watts SW
Hypertension; 2002 Feb; 39(2 Pt 2):394-8. PubMed ID: 11882579
[TBL] [Abstract][Full Text] [Related]
12. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
Sekihara H; Yazaki Y; Kojima T
J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
[TBL] [Abstract][Full Text] [Related]
13. Structural, functional and hypertensive effects of 19-oxo-11-deoxycorticosterone acetate (19-oxo-DOCA) in the rat.
Hall CE; Gomez-Sanchez CE; Hungerford S
Steroids; 1983 May; 41(5):627-35. PubMed ID: 6658894
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats.
Pietranera L; Saravia F; Roig P; Lima A; De Nicola AF
Neuroendocrinology; 2004; 80(2):100-10. PubMed ID: 15475662
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
[TBL] [Abstract][Full Text] [Related]
16. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
Alvarez G; Osuna A; Wangensteen R; Vargas F
Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
[TBL] [Abstract][Full Text] [Related]
17. Ouabain as an amplifier of mineralocorticoid-induced hypertension.
Sekihara H; Yazaki Y; Kojima T
Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641
[TBL] [Abstract][Full Text] [Related]
18. Effects of adrenalectomy and nephrectomy on adrenal regeneration hypertension in the rat.
Chan JY; Chan SH
Proc Natl Sci Counc Repub China B; 1991 Oct; 15(4):197-205. PubMed ID: 1815260
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe.
Khalid BA; Lim AT; Fraillon DR; Funder JW
J Clin Invest; 1982 Aug; 70(2):443-52. PubMed ID: 6284802
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid and mineralocorticoid effects on adrenocorticotropin and beta-endorphin in the adrenalectomized rat.
Lim AT; Khalid BA; Clements J; Funder JW
J Clin Invest; 1982 May; 69(5):1191-8. PubMed ID: 6279699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
